Technology area: Biotechnology & Pharmaceuticals
8 pending office actions • 4 clients • 8 examiners • 6 art units • 0 of 8 (0%) have an AI response strategy ready • 21 patents granted in the last 365 days
This profile covers Biotechnology & Pharmaceuticals and includes 625 career applications. The resolved allowance rate is 78.82%, and the average is 3.24 office actions per allowance. These figures describe a substantial prosecution record with allowance outcomes reported for most, but not all, resolved matters and several examination interactions associated with allowance.
The profile has 8 pending office actions, which identifies a current group requiring prosecution attention alongside the historical record. For counsel, the allowance rate provides an outcome measure, while the action average gives context on examination persistence. Those measures should be read together when planning responses, continuation strategy, and client expectations for biotechnology and pharmaceutical cases.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 5 (62%) |
| §112 only | 2 (25%) |
| Double-patenting only | 1 (12%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BANERJEE, KOYELI | 1 | 33.3% | +0.0% |
| KONOPELSKI SNAVEL, SARA ELIZABETH | 1 | 35.0% | +35.4% |
| KATAKAM, SUDHAKAR | 1 | 74.8% | +23.3% |
| KUDO, KEN | 1 | — | — |
| YOON, CHANEL J | 1 | 55.5% | +39.3% |
| HOWARD, ZACHARY C | 1 | 63.9% | +37.7% |
| KANE, TREVOR LOGAN | 1 | 68.8% | +53.3% |
| BLUMEL, BENJAMIN P | 1 | 70.7% | +30.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17760180 | POLYPEPTIDES AND THEIR USE | BLUMEL, BENJAMIN P | 21d |
| 18547897 | Methods and Devices to Measure Angular Stiffness of Dental and Medical Implants | YOON, CHANEL J | 27d |
| 18814954 | Reagents and methods for treating bacterial infection | BANERJEE, KOYELI | — |
| 18799107 | De novo designed sequence-specific DNA binding proteins | KONOPELSKI SNAVEL, SARA ELIZABETH | — |
| 18463683 | Processing Images to Associate with Stages of a Surgical Procedure | KUDO, KEN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17760180 | POLYPEPTIDES AND THEIR USE | BLUMEL, BENJAMIN P | 21d |
| 18547897 | Methods and Devices to Measure Angular Stiffness of Dental and Medical Implants | YOON, CHANEL J | 27d |
| 18799107 | De novo designed sequence-specific DNA binding proteins | KONOPELSKI SNAVEL, SARA ELIZABETH | — |
| 18576518 | MULTIPLE DE NOVO DESIGNED PROTEIN BINDING PROTEINS | KATAKAM, SUDHAKAR | — |
| 18257719 | Methods and Systems for Quantifying Lipoprotein(A) Using Candidate References | HOWARD, ZACHARY C | — |
| 17931704 | COMPOSITIONS AND METHODS FOR TREATING CELIAC SPRUE DISEASE | KANE, TREVOR LOGAN | — |
| Client (Assignee) | Pending OAs |
|---|---|
| University of Washington | 5 |
| Seattle Children's Hospital (dba Seattle Children's Research Institute) | 1 |
| Western University | 1 |
| University of California | 1 |
| Art Unit | Apps |
|---|---|
| 1658 | 3 |
| 2671 | 1 |
| 3791 | 1 |
| 1674 | 1 |
| 1657 | 1 |
| 1671 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18814954 | Reagents and methods for treating bacterial infection | UNIVERSITY OF WASHINGTON | BANERJEE, KOYELI | 1658 | §101§102§103§112DP | Non-Final OA | — | Pending | Aug 26, 2024 |
| 18799107 | De novo designed sequence-specific DNA binding proteins | UNIVERSITY OF WASHINGTON | KONOPELSKI SNAVEL, SARA ELIZABETH | 1658 | §101§102§112 | Non-Final OA | — | Pending | Aug 09, 2024 |
| 18576518 | MULTIPLE DE NOVO DESIGNED PROTEIN BINDING PROTEINS | UNIVERSITY OF WASHINGTON | KATAKAM, SUDHAKAR | 1658 | §112 | Non-Final OA | — | Pending | Jan 04, 2024 |
| 18463683 | Processing Images to Associate with Stages of a Surgical Procedure | Seattle Children'S Hospital D/B/A Seattle Children'S Research Institute | KUDO, KEN | 2671 | §101§102§103§112 | Non-Final OA | — | Pending | Sep 08, 2023 |
| 18547897 | Methods and Devices to Measure Angular Stiffness of Dental and Medical Implants | UNIVERSITY OF WASHINGTON | YOON, CHANEL J | 3791 | §101§102§103§112Other | Non-Final OA | 27d | Pending | Aug 25, 2023 |
| 18257719 | Methods and Systems for Quantifying Lipoprotein(A) Using Candidate References | The University of Western Ontario | HOWARD, ZACHARY C | 1674 | §112 | Non-Final OA | — | Pending | Jun 15, 2023 |
| 17931704 | COMPOSITIONS AND METHODS FOR TREATING CELIAC SPRUE DISEASE | The Regents of the University of California | KANE, TREVOR LOGAN | 1657 | DP | Non-Final OA | — | Pending | Sep 13, 2022 |
| 17760180 | POLYPEPTIDES AND THEIR USE | UNIVERSITY OF WASHINGTON | BLUMEL, BENJAMIN P | 1671 | §101§102§103§112 | Final Rejection | 21d | Pending | Aug 04, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial78.8% of resolved applications prosecuted by Mbhb - Uw were allowed, across 625 applications in USPTO records.
3.24 office actions per allowed application on average.
8 pending office actions as of October 2026, for 4 clients, before 8 examiners in 6 art units.
